Initial Development and Dissemination of OC-Go

Obsessive-Compulsive Disorder Clinical Trial

— OC-GoPhaseI  

Official title:

Facilitating Fidelity and Dissemination of Evidence Based Treatment for Childhood OCD Via an Interactive Crowd-sourced Patient-provider Tool

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03126305
• Other study ID #: R42MH111277-01A1
• Status: Completed
• Start date: May 1, 2017
• Est. completion date: April 30, 2018

Study information

• Verified date: November 2020
• Source: University of California, Los Angeles
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The clinical component of Phase I application development examines the clinical utility, feasibility, and functionality of the OC-Go application via an 8-month pilot trial consisting of 50 standard CBT sessions augmented with OC-Go in OCD-diagnosed children who are receiving treatment through the pediatric OCD treatment programs in the UCLA Division of Child and Adolescent Psychiatry

Description:

This project seeks to refine and assess OC-Go, a HIPAA-compliant web-based clinician portal and patient-side mobile application designed to increase patient adherence to evidence-based treatment (EBT) for Obsessive Compulsive Disorder (OCD), a common and impairing condition, and provider ability to effectively implement EBTs. OC-Go allows clinicians to create and push tailored assignments to patients on their mobile devices with an optimized user interface that includes patient accountability and support features. Accordingly, patients can be guided to do assignments by themselves between sessions with increased fidelity over the course of treatment. Once therapy assignments are created and shared to a crowd-sourced and curated public library, any clinician can assign any task to any patient for homework or in-session use with one touch. Use of OC-Go is expected to increase patient engagement, compliance, treatment efficiency, dissemination of EBTs, and therapist confidence and expertise.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8
• Est. completion date: April 30, 2018
• Est. primary completion date: April 30, 2018
• Gender: All
• Age group: 9 Years to 17 Years

Eligibility

Inclusion Criteria:

• Children receiving exposure based CBT through the UCLA Child OCD, Anxiety and Tic Disorders Clinic or Pediatric OCD Intensive Outpatient Program and their parents

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Obsessive-Compulsive Disorder

Intervention

Other:
• OC-Go
OC-Go, a HIPAA-compliant web-based clinician portal and patient-side mobile application that allows clinicians to create and push tailored treatment assignments to patients on their mobile devices

Locations

Country	Name	City	State
United States	Univ. of California / Los Angeles / Semel Inst.	Los Angeles	California

Sponsors (2)

Lead Sponsor	Collaborator
University of California, Los Angeles	Virtually Better, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	System Usability Scale (SUS)	10-item self-report measure assessing the usability of the OC-Go application	6 weeks
Primary	Usability Evaluation for e-Learning Applications (UELA),	54-item self-report measure assessing the usability of the OC-Go application	6 weeks